Cardiogenic shock without hypotension in acute severe primary mitral regurgitation: a case report-Reference-Cited by-同舟云学术

Cardiogenic shock without hypotension in acute severe primary mitral regurgitation: a case report

Published:2024-05-01 Issue:5 Volume:2024 Page:
ISSN:2053-8855
Container-title:Oxford Medical Case Reports
language:en
Short-container-title:

Author:

Saunders Samantha L¹²^ORCID,Clifford Liam M³,Meere William¹,Spina Roberto¹

Affiliation:

1. Department of Cardiology, Gosford Hospital , Gosford NSW, Australia

2. School of Medicine and Public Health, The University of Newcastle , Newcastle NSW, Australia

3. Department of Endocrinology, Gosford Hospital , Gosford NSW, Australia

Abstract

Abstract A 60-year-old gentleman who presented with features of end-organ hypoperfusion despite initial hypertension was promptly diagnosed with cardiogenic shock following evidence of hyperlactatemia on biochemistry and left ventricular global hypokinesis with severe mitral regurgitation on transthoracic echocardiogram. He responded well to dobutamine and later underwent definitive surgical mitral valve replacement.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/omcr/article-pdf/2024/5/omae018/59100408/omae018.pdf

Reference13 articles.

1. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC;McDonagh;Eur Heart J,2021

2. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry;Menon;Am J Med,2000

3. A standardized and comprehensive approach to the management of cardiogenic shock;Tehrani;JACC Heart Fail,2020

4. Cardiogenic shock without hypotension in acute myocardial infarction;Caldeira Da Rocha,2021

5. Patients near to cardiogenic shock (CS) but without hypotension have similar prognosis when compared to patients with classic CS: is it time for redefine CS? A FRENSHOCK multicenter registry analysis;Delmas;Arch Cardiovasc Dis Suppl,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature;International Journal of Molecular Sciences;2024-07-24